Figure 4.
Kaplan–Meier curves for drug retention in patients with first detectable ATI <8.8 U/ml (dotted line) compared to those with ATI ≥8.8 U/ml (solid line).
ATI: antibodies to infliximab.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.